Skip to main content
Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
42.37
+0.82 (1.99%)
At close: Mar 9, 2026, 4:00 PM EDT
42.37
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:20 PM EDT

Exelixis Market Cap

Exelixis has a market cap or net worth of $11.00 billion as of March 9, 2026. Its market cap has increased by 12.04% in one year.

Market Cap
11.00B
Enterprise Value
9.54B
1-Year Change
12.04%
Ranking
#882
Category
Large-Cap
Stock Price
$42.37

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $11.00B, an increase of 1,644.43%. That is a compound annual growth rate of 11.67%.

History

DateMarket Cap% Change
Mar 6, 202610.79B-8.18%
Dec 31, 202511.75B23.57%
Dec 31, 20249.51B27.47%
Dec 29, 20237.46B44.19%
Dec 30, 20225.17B-10.54%
Dec 31, 20215.78B-7.11%
Dec 31, 20206.23B16.30%
Dec 31, 20195.35B-8.96%
Dec 31, 20185.88B-34.61%
Dec 29, 20178.99B110.58%
Dec 30, 20164.27B233.29%
Dec 31, 20151.28B355.89%
Dec 31, 2014281.10M-75.11%
Dec 31, 20131.13B34.59%
Dec 31, 2012839.00M36.62%
Dec 30, 2011614.10M-31.37%
Dec 31, 2010894.80M13.07%
Dec 31, 2009791.40M49.29%
Dec 31, 2008530.10M-41.23%
Dec 31, 2007902.00M4.64%
Dec 29, 2006862.00M10.08%
Dec 30, 2005783.10M10.19%
Dec 31, 2004710.70M41.83%
Dec 31, 2003501.10M9.05%
Dec 31, 2002459.50M-44.16%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
BridgeBio Pharma 12.67B
Ionis Pharmaceuticals 12.23B
BioMarin Pharmaceutical 11.75B
Summit Therapeutics 11.72B
Jazz Pharmaceuticals 11.20B
Madrigal Pharmaceuticals 9.93B
ImmunityBio 8.91B
Praxis Precision Medicines 8.65B
Market Cap Rankings